Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Wilson_Therapeutics> ?p ?o }
Showing triples 1 to 61 of
61
with 100 triples per page.
- Wilson_Therapeutics abstract "Wilson Therapeutics is a privately held biopharmaceutical company focused on developing novel treatments for Wilson's disease, a rare genetic disease that affects approximately 1 in 15,000. Wilson Therapeutics was founded in 2012 by HealthCap, one of the leading European life science venture capital funds. In April 2014, Wilson Therapeutics announced that it had closed a $40 million Series B financing co-led by new investors, Abingworth LLP and MVM Life Science Partners LLP. HealthCap, also participated in the round. The funds will be used to advance the clinical development of WTX101. Wilson Therapeutics’ lead compound, WTX101 (previously called ATN-224), is the proprietary bis-choline salt of tetrathiomolybdate. Tetrathiomolybdate is a novel de-coppering agent, meaning it reduces the body’s level of copper with high affinity and selectivity for copper. Tetrathiomolybdate has been tested in several clinical trials in Wilson's disease where it has been shown to rapidly lower copper levels, stabilizing neurological function with a reduced risk of neurological deterioration after initiation of treatment in Wilson’s disease patients with neurological disease. WTX101 has been granted orphan drug designation for the treatment of Wilson's disease in both Europe and the United States".
- Wilson_Therapeutics foundingYear "2012".
- Wilson_Therapeutics product Bis-choline_tetrathiomolybdate.
- Wilson_Therapeutics wikiPageExternalLink www.wilsontherapeutics.com.
- Wilson_Therapeutics wikiPageID "43152107".
- Wilson_Therapeutics wikiPageLength "11954".
- Wilson_Therapeutics wikiPageOutDegree "21".
- Wilson_Therapeutics wikiPageRevisionID "679835403".
- Wilson_Therapeutics wikiPageWikiLink Bis-choline_tetrathiomolybdate.
- Wilson_Therapeutics wikiPageWikiLink Category:Genetic_disorders.
- Wilson_Therapeutics wikiPageWikiLink Category:Medical_research_organizations.
- Wilson_Therapeutics wikiPageWikiLink Category:Orphan_drugs.
- Wilson_Therapeutics wikiPageWikiLink Category:Pharmaceutical_companies.
- Wilson_Therapeutics wikiPageWikiLink Category:Pharmaceutical_industry.
- Wilson_Therapeutics wikiPageWikiLink Category:Rare_diseases.
- Wilson_Therapeutics wikiPageWikiLink Cognitive_deficit.
- Wilson_Therapeutics wikiPageWikiLink Copper.
- Wilson_Therapeutics wikiPageWikiLink File:Wilson_Therapeutics_Company_Logo.png.
- Wilson_Therapeutics wikiPageWikiLink Genetic_disorder.
- Wilson_Therapeutics wikiPageWikiLink HealthCap.
- Wilson_Therapeutics wikiPageWikiLink Neurological_disorder.
- Wilson_Therapeutics wikiPageWikiLink Oncology.
- Wilson_Therapeutics wikiPageWikiLink Orphan_drug.
- Wilson_Therapeutics wikiPageWikiLink Wilsons_disease.
- Wilson_Therapeutics wikiPageWikiLinkText "Wilson Therapeutics".
- Wilson_Therapeutics wikiPageWikiLinkText "study".
- Wilson_Therapeutics foundation "2012".
- Wilson_Therapeutics hasPhotoCollection Wilson_Therapeutics.
- Wilson_Therapeutics homepage www.wilsontherapeutics.com.
- Wilson_Therapeutics industry "Pharmaceutical Industry".
- Wilson_Therapeutics locationCity "Stockholm".
- Wilson_Therapeutics locationCountry "Sweden".
- Wilson_Therapeutics logo File:Wilson_Therapeutics_Company_Logo.png.
- Wilson_Therapeutics name "Wilson Therapeutics AB".
- Wilson_Therapeutics products "Choline tetrathiomolybdate; Bis tetrathiomolybdate; ATN-224; WTX101".
- Wilson_Therapeutics type "Private Company".
- Wilson_Therapeutics wikiPageUsesTemplate Template:Infobox_company.
- Wilson_Therapeutics wikiPageUsesTemplate Template:Reflist.
- Wilson_Therapeutics subject Category:Genetic_disorders.
- Wilson_Therapeutics subject Category:Medical_research_organizations.
- Wilson_Therapeutics subject Category:Orphan_drugs.
- Wilson_Therapeutics subject Category:Pharmaceutical_companies.
- Wilson_Therapeutics subject Category:Pharmaceutical_industry.
- Wilson_Therapeutics subject Category:Rare_diseases.
- Wilson_Therapeutics type Agent.
- Wilson_Therapeutics type Company.
- Wilson_Therapeutics type Organisation.
- Wilson_Therapeutics type Organization.
- Wilson_Therapeutics type Agent.
- Wilson_Therapeutics type SocialPerson.
- Wilson_Therapeutics type Thing.
- Wilson_Therapeutics type Q43229.
- Wilson_Therapeutics comment "Wilson Therapeutics is a privately held biopharmaceutical company focused on developing novel treatments for Wilson's disease, a rare genetic disease that affects approximately 1 in 15,000. Wilson Therapeutics was founded in 2012 by HealthCap, one of the leading European life science venture capital funds. In April 2014, Wilson Therapeutics announced that it had closed a $40 million Series B financing co-led by new investors, Abingworth LLP and MVM Life Science Partners LLP.".
- Wilson_Therapeutics label "Wilson Therapeutics".
- Wilson_Therapeutics sameAs m.011vb6zk.
- Wilson_Therapeutics sameAs Q18395077.
- Wilson_Therapeutics sameAs Q18395077.
- Wilson_Therapeutics wasDerivedFrom Wilson_Therapeutics?oldid=679835403.
- Wilson_Therapeutics homepage www.wilsontherapeutics.com.
- Wilson_Therapeutics isPrimaryTopicOf Wilson_Therapeutics.
- Wilson_Therapeutics name "Wilson Therapeutics AB".